Electromed

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Electromed reports record Q1 revenues, faces CMS waiver expiration

Electromed delivered robust financial performance, driven by strong revenue growth and operational efficiency. The company faces challenges related to potential CMS waiver expiration and CEO succession, but strategic initiatives and market opportunities position it for continued growth. Overall, Electromed's focus on innovation and market expansion bodes well for future success.

Electromed reports record Q2 revenue, focuses on strategic growth

Electromed's Q2 2023 earnings call showcased strong financial performance, particularly in the home care segment. Despite challenges from the expiration of the CMS waiver, the company's strategic growth initiatives and clinical evidence present promising opportunities for future success.

Electromed Inc. reports robust Q3 earnings and targets market expansion

Electromed Inc. delivered strong financial performance in Q3 2023, driven by revenue growth and improved operational efficiency. The company's strategic initiatives and focus on quality assurance position it for continued success. However, managing expenses and balancing revenue across segments will be crucial for sustained growth.

Electromed (ELMD) reports record revenue and eyes growth opportunities

Electromed's Q4 2023 earnings call showcased impressive financial performance, with record revenue and operating income. The company's strategic focus on growth investments, operational excellence, and market development is driving strong results. While facing challenges in optimizing capital deployment, Electromed is well-positioned to leverage opportunities in expanding its market presence and driving further growth.

Electromed (ELMD) achieves record revenue in Q3 2024 earnings call

Electromed (ELMD) delivered robust financial performance in Q3 2024, driven by revenue growth and operational excellence. Despite challenges like a cyberattack and increased expenses, the company remains well-positioned with a strong cash position and growth strategies in place.

Electromed (ELMD) achieves record revenue and market expansion in Q4 2024

Electromed's Q4 2024 performance reflects strong revenue growth, operational excellence, and strategic market initiatives.
While facing challenges in maintaining growth momentum, the company's focus on innovation and market expansion positions it for future success.
With a solid financial position, diverse product portfolio, and growth strategies in place, Electromed is poised for continued growth and market leadership.

Electromed (ELMD) reports robust Q1 earnings and strategic growth plans

Electromed's Q1 2025 performance reflects strong revenue growth, improved profitability, and strategic investments in key areas.
The company's financial stability, operational efficiency, and focus on market expansion position them for sustained success in the medical device industry.
While challenges in maintaining growth persist, Electromed's proactive approach to innovation and market awareness presents opportunities for future expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q1 2021 Results - Earnings Call Transcript

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2020 (“Q1 FY 2021”). Q1 FY 2021 Highlights Net revenue was $8.0 million, down 3.6% compared to the three months ended September 30, 2019 (“Q1 FY 2020”), primarily reflecting lower institutional revenue due to the continued impact of COVID-19 on hospital purchasi

Electromed, Inc. Announces Fiscal 2021 First Quarter Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 first quarter ended September 30, 2020 on Tuesday, November 10, 2020 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by d

Electromed, Inc. Schedules its First Quarter Fiscal 2021 Financial Results Conference Call for November 10, 2020 at 5:00 p.m. ET

Electromed has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Electromed Enters Oversold Territory

Fresenius Medical Care

NextGen Healthcare Inc

Tivity Health

Here are some MedTech growth stocks which might be solid investment options for profit-maximization amid the coronavirus-led market mayhem.

4 MedTech Growth Stocks With Strong ROE to Buy Amid Coronavirus

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc.

Electromed, Inc. to Participate in the 2020 Colliers Institutional Investor Conference

Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q4 2020 Results - Earnings Call Transcript

Electromed, Inc. Announces Fiscal 2020 Fourth Quarter and Full Year Financial Results

Electromed, Inc. Schedules its Fourth Quarter Fiscal 2020 Financial Results Conference Call for August 25, 2020 at 5:00 p.m.

Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q3 2020 Results - Earnings Call Transcript

GAIN Capital Hlds

21Vianet Group

Vista Outdoor

In order to select the right breakout stock one has to first calculate its support and resistance level.

4 Breakout Stocks - for Explosive Returns

AudioEye Inc

Fiverr

Sprouts Farmers Markets

Coronavirus is going to be around for a while, so let's use it to define our investment strategies.

5 Themes (& Picks) for Coronavirus Investing

FTI Consulting

Eli Lilly

Masimo

Novagold Resources

Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

5 Stocks With Recent Price Strength Amid Coronavirus Logjam

eHealth

QIAGEN

WD-40

The global financial markets are currently witnessing one of the worst periods since the Great Depression due to the coronavirus-led crisis.

5 Top Low-Beta Stocks Surged in March Defying Coronavirus

CNA Financial

Pacira Pharmaceuticals

Regeneron Pharmaceuticals

Top Ranked Momentum Stocks to Buy for February 21st

As of late, it has definitely been a great time to be an investor of Electromed, Inc. (ELMD).

Electromed, Inc. (ELMD) Shares March Higher, Can It Continue?

Electromed's (ELMD) CEO Kathleen Skarvan on Q2 2020 Results - Earnings Call Transcript

Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q1 2020 Results - Earnings Call Transcript

Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q4 2019 Results - Earnings Call Transcript

There is an activist driven initiative to enhance shareholder value.

Electromed Revs Up By Slimming Down

Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q3 2019 Results - Earnings Call Transcript

News for Electromed Stock (ELMD)